Papers

3

Total Citations

59

H-Index

2

About

Toni Vu is a radiation oncologist whose research focuses on optimizing stereotactic body radiotherapy (SBRT) for lung cancer, with a particular emphasis on patient-adapted robotic techniques. Her major contributions include demonstrating excellent cancer outcomes for early-stage non-small cell lung cancer patients treated with Cyberknife SBRT, as detailed in her most-cited work (33 citations), which also importantly highlighted cautionary outcomes for patients with idiopathic pulmonary fibrosis. Vu further advanced the field by investigating long-term quality of life following robotic stereotactic ablative radiation therapy (24 citations), providing critical patient-centered evidence that treatment preserves functional well-being. Her work on breath-hold CT accuracy for lung SBRT treatment planning (2 citations) addressed technical precision in tumor targeting. Through these studies, Vu has helped refine SBRT delivery by balancing tumor control with toxicity risks, particularly for vulnerable populations. Her research underscores the importance of individualized treatment approaches in radiation oncology, making her a notable contributor to the evidence base guiding modern lung cancer radiotherapy.

Research Focus

Key Achievements

2
H-Index
3
Papers
59
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis
33 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago